231 filings
Page 5 of 12
S-8
0cpqaf8wj t9pkix823j
11 Aug 20
Registration of securities for employees
4:26pm
8-K
52rn9qt6 zu
11 Aug 20
Results of Operations and Financial Condition
7:01am
EFFECT
r21c0e7fgd9u3p htu
16 Jun 20
Notice of effectiveness
12:15am
S-3/A
9o0jja
11 Jun 20
Shelf registration (amended)
4:48pm
CORRESP
xpu97i
11 Jun 20
Correspondence with SEC
12:00am
8-K
c0bgrj5q17lu704u14
10 Jun 20
Axovant Announces Year-End Financial Results and Expected Key Clinical Milestones in Q4 2020
6:02am
8-K
rzfydjv pr5msh9uo
29 Apr 20
Entry into a Material Definitive Agreement
5:00pm
424B5
ok7dr bk23aiheph
29 Apr 20
Prospectus supplement for primary offering
4:55pm
8-K
f1ybhwevicx tvgjfj
24 Apr 20
Other Events
7:31am
8-K
0popqfpyvktfv07p2c
20 Apr 20
Termination of a Material Definitive Agreement
5:21pm
8-K
67d1l 5pz03jkm
26 Mar 20
Amendments to Articles of Incorporation or Bylaws
4:15pm
DEF 14C
cbqrwxtgqm0zooo8z
2 Mar 20
Information statement
6:03am
8-K
50oa51km5c o8hf227
21 Feb 20
Other Events
5:16pm
424B5
cr4uojtmquu xs
21 Feb 20
Prospectus supplement for primary offering
12:00am
424B5
hog8b2ii9m7ec8b
19 Feb 20
Prospectus supplement for primary offering
5:28pm
PRE 14C
325 hi4ic
19 Feb 20
Preliminary information
7:32am
8-K
iopk 6obvdhtiquxrnmz
19 Feb 20
Departure of Directors or Certain Officers
6:01am